8/8/2019 Drug Study- Cefazolin Doxycycline

1/2

DRUG STUDY

Name ofDrug

Generic/Brand

DateOrdered

Classification Dose/Frequency

Mechanismof Action

SpecificIndication

Contraindication Side Effects NusingPrecaution

Doxycycline(Chlamadox)

STAT MEDS

Cefazolin(Hazolin)

1-23-10

Antibiotic, Anti-infectives

Antibiotic, Anti-infectives

100 mg itab q 12h

P.O.

IVTT(-)ANST

Semisyntheticbroad-

spectrumtetraclcieantibiotic.Morecompletelyabsorbed.Primarilybacterostaticin action.

Semisynthetic,firstgenerationderivative ofCephalosporinC. Bactericidalin action.Inhibits third

Chlamydiland

mycoplasmalinfections

Severeinfections ofurinary andbiliary tractscaused bysusceptibleorganisms.Preoperaitve

Sensitivity to anyof the tetracyclines

Hypersensitivity toany cephalosporinand relatedantibiotics.

Interferencewith color

vision,anorexia,Nausea,vomiting,diarrhea,photosensitivity,rashes

Diarrhea,anorexia,abdominalcramps,anaphylaxis,urticuria, fever,superinfections

*Checkexpiration

date.Degradationproducts oftetracyclinearenephrotoxic.*Oraldoxycyclinemay be

taken withfood or milkto minimizenauseawithoutaffectingbioavailabilityof drug.

*IM injectionsshould bemade deepinto largemusclemass. Painon injectionsite is usually

8/8/2019 Drug Study- Cefazolin Doxycycline

2/2

and final stageof bacterialcell wallsynthesis,thus killing thebacterium.

prophylaxisin patientsundergoingproceduresassociatedby high riskof infection.

minimal.rotateinjectionsites.*Monitorintake andoutput rationand pattern.Be alert tochanges inBUN, serumcreatinine.